Glenmark Pharmaceuticals Limited

FDA inspection history across 3 sites, 2017 to 2022

3
Form 483s
1
Close-out

Every document, by year

  • Form 483
  • Close-out

2017: one Form 483; 2019: one close-out letter and one Form 483; 2022: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2017–19Two Form 483s and one close-out letter, at Solan, India; Mumbai, India and Baddi, India.
  2. 2022One Form 483, at Baddi, India.
  3. 2022The longest 483 on file: 6 observations over 7 pages at Baddi, India.

Cited most

Across all Glenmark Pharmaceuticals Limited observations on file

The complete Glenmark Pharmaceuticals Limited file.

All 4 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$396

The price of the documents, added to your cart together

Sites

Documents

4 on file, newest first
DateDocumentPrice
2022-06-22483 Form 483$99
2019-10-03Close-out Close-out letter$99
2019-04-20483 Form 483$99
2017-11-11483 Form 483$99

FEI number 3005757050 · most recent document Jun 22, 2022

About Glenmark Pharmaceuticals Limited

How many FDA Form 483s has Glenmark Pharmaceuticals Limited received?

FDA Intel has 3 Form 483s on file for Glenmark Pharmaceuticals Limited; the most recent is dated Jun 22, 2022.

When was Glenmark Pharmaceuticals Limited last inspected by FDA?

The most recent FDA inspection document on file for Glenmark Pharmaceuticals Limited is a Form 483 dated Jun 22, 2022, for the site in Baddi, India.

What did FDA cite at Glenmark Pharmaceuticals Limited?

The regulations cited most in the observations on file for Glenmark Pharmaceuticals Limited are 21 CFR 211.192 (Production record review), 4 times; 21 CFR 211.198 (Complaint files), 2 times; 21 CFR 211.67 (Equipment cleaning and maintenance), 2 times.

Glenmark Pharmaceuticals Limited FDA Inspection History & 483s · FDA Intel